Glioma cell motility, proliferation, and stem cell self-renewal ability are all markedly reduced when SH3KBP1 is silenced, both in vitro and in vivo when xenograft tumors are growing (48). The gene discussed is SH3KBP1; the disease is central nervous system cancer.